Biologics for Asthma & Eczema

Biologics have revolutionized the treatment landscape for both asthma and atopic dermatitis (eczema), offering new hope for patients who struggle with these conditions. Specifically designed to target the underlying causes of these diseases, biologics are medications created from living organisms or their components. They work by modulating the immune system to reduce inflammation and control symptoms.

For asthma, biologics like omalizumab (Xolair), mepolizumab (Nucala), benralizumab (Fasenra), and dupilumab (Dupixent) have shown remarkable efficacy in managing severe, uncontrolled asthma. These medications target specific pathways in the immune system, reducing exacerbations and improving overall lung function.

In the realm of atopic dermatitis, Dupixent has emerged as a groundbreaking biologic. It's specifically approved for moderate to severe cases of atopic dermatitis and has shown significant success in reducing itching, inflammation, and the severity of skin lesions.

At Maryland Allergy & Asthma Center, we specialize in comprehensive care for asthma and atopic dermatitis patients. Our team is well-versed in the latest advancements in biological treatments and strives to provide individualized care plans tailored to each patient's unique needs.

If you or someone you know is struggling with severe asthma or atopic dermatitis that isn't responding to conventional treatments, we encourage you to schedule an appointment with us. Our board-certified allergist will conduct a thorough assessment, discuss the available treatment options, including biologics, and work with you to develop a personalized plan aimed at improving your quality of life.

Taking proactive steps toward managing these conditions can make a significant difference in your symptoms and overall well-being. Reach out to Maryland Allergy & Asthma Center today to schedule your appointment and start your journey toward better health and symptom control.